Hemostatic abnormalities in patients with Ehlers –Danlos syndrome
ConclusionsOur results show that nearly half of patients with EDS have an abnormal BSS, which, in 90% of cases, appear, at least in part, to be attributable to platelet function abnormalities. Abnormalities of primary hemostasis may contribute to the risk of bleeding in patients with EDS.
Source: Journal of Thrombosis and Haemostasis - Category: Hematology Authors: A. Artoni,
A. Bassotti,
M. Abbattista,
B. Marinelli,
A. Lecchi,
F. Gianniello,
M. Clerici,
P. Bucciarelli,
S. La Marca,
F. Peyvandi,
I. Martinelli Tags: Original Article Source Type: research
More News: Bleeding | Ehlers-Danlos Syndrome | Hematology | Skin | Study | Thrombosis | von Willebrand Disease | Women